News

Alvotech (NASDAQ:ALVO) and Dr. Reddy’s Laboratories (NYSE:RDY) have entered into a collaboration and license agreement to ...
Procter & Gamble said Thursday it plans to cut 7,000 jobs, about 15% of its workforce, over two years. The company said it's ...
U.S. aid cuts could jeopardize the supply of donated drugs that are hailed for their effectiveness in combating neglected ...
An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.
Bill Stone, Glenview Trust Company chief investment officer, mentioned his bullish take on Merck (NYSE:MRK) during a recent ...
Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...
The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...
US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...
Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...
The latest edition of "Column Watch" features our annual review of new liquid chromatography columns and accessories, ...
Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...
The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...